Genetic sources of subcomponents of event-related potential in the dimension of psychosis analyzed from the B-SNIP study

American Journal of Psychiatry

Volumn 172, Issue 5, 2015, Pages 466-478

  Narayanan, Balaji ^a   Ethridge, Lauren E ^a   O'Neil, Kasey ^a   Dunn, Sabra ^a   Mathew, Ian ^a   Tandon, Neeraj ^a   Calhoun, Vince D ^a   Ruaño, Gualberto ^a   Kocherla, Mohan ^a   Windemuth, Andreas ^a   Clementz, Brett A ^a   Tamminga, Carol A ^a   Sweeney, John A ^a   Keshavan, Matcheri S ^a   Pearlson, Godfrey D ^a  

^a INSTITUTE OF LIVING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; AUDITORY STIMULATION; BIPOLAR DISORDER; BRAIN FUNCTION; CELL ADHESION; CONTROLLED STUDY; EVENT RELATED POTENTIAL; GENE CLUSTER; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; IMMUNE RESPONSE; INDEPENDENT COMPONENT ANALYSIS; MAJOR CLINICAL STUDY; NERVOUS SYSTEM DEVELOPMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PSYCHOSIS; RISK FACTOR; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; TASK PERFORMANCE; WAVEFORM; EVOKED AUDITORY RESPONSE; FEMALE; GENETICS; MALE; MIDDLE AGED; MULTIGENE FAMILY; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOTIC DISORDERS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIPOLAR DISORDER; EVOKED POTENTIALS, AUDITORY; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIGENE FAMILY; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84928962955     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2014.13101411     Document Type: Article

References (96)

1. Hill SK, Reilly JL, Harris MS, et al: A comparison of neuropsychological dysfunction in first-episode psychosis patients with unipolar depression, bipolar disorder, and schizophrenia. Schizophr Res 2009; 113:167-175
2. Chai XJ, Whitfield-Gabrieli S, Shinn AK, et al: Abnormal medial prefrontal cortex resting-state connectivity in bipolar disorder and schizophrenia. Neuropsychopharmacology 2011; 36:2009-2017
3. Carpenter WT, Bustillo JR, Thaker GK, et al: The psychoses: cluster 3 of the proposed meta-structure for DSM-V and ICD-11. Psychol Med 2009; 39:2025-2042
4. Bramon E, Sham PC: The common genetic liability between schizophrenia and bipolar disorder: a review. Curr Psychiatry Rep 2001; 3:332-337
5. Smoller JW, Craddock N, Kendler K, et al: Identification of risk loci with shared effects on five major psychiatric disorders: a genomewide analysis. Lancet 2013; 381:1371-1379
6. Eastwood SL, Harrison PJ: Hippocampal synaptic pathology in schizophrenia, bipolar disorder, and major depression: a study of complexin mRNAs. Mol Psychiatry 2000; 5:425-432
7. Grozeva D, Kirov G, Ivanov D, et al: Rare copy number variants: a point of rarity in genetic risk for bipolar disorder and schizophrenia. Arch Gen Psychiatry 2010; 67:318-327
8. Purcell SM, Wray NR, Stone JL, et al: Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009; 460:748-752
9. Gottesman II, Gould TD: The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003; 160:636-645
10. Polich J: Updating P300: an integrative theory of P3a and P3b. Clin Neurophysiol 2007; 118:2128-2148
11. van Beijsterveldt CE, van Baal GC, Molenaar PC, et al: Stability of genetic and environmental influences on P300 amplitude: a longitudinal study in adolescent twins. Behav Genet 2001; 31:533-543
12. O'Donnell BF, Vohs JL, Hetrick WP, et al: Auditory event-related potential abnormalities in bipolar disorder and schizophrenia. Int J Psychophysiol 2004; 53:45-55
13. Ethridge LE, Hamm JP, Shapiro JR, et al: Neural activations during auditory oddball processing discriminating schizophrenia and psychotic bipolar disorder. Biol Psychiatry 2012; 72:766-774
14. Winterer G, Egan MF, Raedler T, et al: P300 and genetic risk for schizophrenia. Arch Gen Psychiatry 2003; 60:1158-1167
15. Turetsky BI, Cannon TD, Gur RE: P300 subcomponent abnormalities in schizophrenia, III: deficits in unaffected siblings of schizophrenic probands. Biol Psychiatry 2000; 47:380-390
16. Bestelmeyer PE, Phillips LH, Crombie C, et al: The P300 as a possible endophenotype for schizophrenia and bipolar disorder: evidence from twin and patient studies. Psychiatry Res 2009; 169: 212-219
17. Schulze KK, Hall MH, McDonald C, et al: Auditory P300 in patients with bipolar disorder and their unaffected relatives. Bipolar Disord 2008; 10:377-386
18. Salisbury DF, Collins KC, McCarley RW: Reductions in the N1 and P2 auditory event-related potentials in first-hospitalized and chronic schizophrenia. Schizophr Bull 2010; 36:991-1000
19. O'Donnell BF, Shenton ME, McCarley RW, et al: The auditory N2 component in schizophrenia: relationship to MRI temporal lobe gray matter and to other ERP abnormalities. Biol Psychiatry 1993; 34:26-40
20. Foxe JJ, Yeap S, Snyder AC, et al: The N1 auditory evoked potential component as an endophenotype for schizophrenia: high-density electrical mapping in clinically unaffected first-degree relatives, first-episode, and chronic schizophrenia patients. Eur Arch Psychiatry Clin Neurosci 2011; 261:331-339
21. Nieuwenhuis S, Aston-Jones G, Cohen JD: Decision making, the P3, and the locus coeruleus-norepinephrine system. Psychol Bull 2005; 131:510-532
22. Pogarell O, Padberg F, Karch S, et al: Dopaminergic mechanisms of target detection: P300 event related potential and striatal dopamine. Psychiatry Res 2011; 194:212-218
23. Mulert C, Juckel G, Giegling I, et al: A Ser9Gly polymorphism in the dopamine D3 receptor gene (DRD3) and event-related P300 potentials. Neuropsychopharmacology 2006; 31:1335-1344
24. Tsai SJ, Yu YW, Chen TJ, et al: Association analysis for dopamine D3 receptor, dopamine D4 receptor, and dopamine transporter genetic polymorphisms and P300 event-related potentials for normal young females. Psychiatr Genet 2003; 13:51-53
25. Liu J, Kiehl KA, Pearlson G, et al: Genetic determinants of target and novelty-related event-related potentials in the auditory oddball response. Neuroimage 2009; 46:809-816
26. Decoster J, De Hert M, Viechtbauer W, et al: Genetic association study of the P300 endophenotype in schizophrenia. Schizophr Res 2012; 141:54-59
27. Bramon E, Dempster E, Frangou S, et al: Neuregulin-1 and the P300 waveform: a preliminary association study using a psychosis endophenotype. Schizophr Res 2008; 103:178-185
28. Gallinat J, Bajbouj M, Sander T, et al: Association of the G1947A COMT (Val(108/158)Met) gene polymorphism with prefrontal P300 during information processing. Biol Psychiatry 2003; 54:40-48
29. Blackwood DH, Fordyce A, Walker MT, et al: Schizophrenia and affective disorders: cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. Am J Hum Genet 2001; 69:428-433
30. Liu J, Demirci O, Calhoun VD: A parallel independent component analysis approach to investigate genomic influence on brain function. IEEE Signal Process Lett 2008; 15:413-416
31. Meda SA, Narayanan B, Liu J, et al: A large scale multivariate parallel ICA method reveals novel imaging-genetic relationships for Alzheimer 's disease in the ADNI cohort. Neuroimage 2012; 60: 1608-1621
32. Meda SA, Ruaño G, Windemuth A, et al: Multivariate analysis reveals genetic associations of the resting default mode network in psychotic bipolar disorder and schizophrenia. Proc Natl Acad Sci USA 2014; 111:E2066-E2075
33. Tamminga CA, Ivleva EI, Keshavan MS, et al: Clinical phenotypes of psychosis in the Bipolar and Schizophrenia Network on Intermediate Phenotypes (B-SNIP). Am J Psychiatry 2013; 170:1263-1274
34. Leavitt VM, Molholm S, Ritter W, et al: Auditory processing in schizophrenia during the middle latency period (10-50 ms): high-density electrical mapping and source analysis reveal subcortical antecedents to early cortical deficits. J Psychiatry Neurosci 2007; 32:339-353
35. Liem F, Zaehle T, Burkhard A, et al: Cortical thickness of supratemporal plane predicts auditory N1 amplitude. Neuroreport 2012; 23:1026-1030
36. Näätänen R, Picton T: The N1 wave of the human electric and magnetic response to sound: a review and an analysis of the component structure. Psychophysiology 1987; 24:375-425
37. Näätänen R, Picton TW: N2 and automatic versus controlled processes. Electroencephalogr Clin Neurophysiol Suppl 1986; 38:169-186
38. Polich J, Criado JR: Neuropsychology and neuropharmacology of P3a and P3b. Int J Psychophysiol 2006; 60:172-185
39. Dutt A, Ganguly T, Shaikh M, et al: Association between hippocampal volume and P300 event related potential in psychosis: support for the Kraepelinian divide. Neuroimage 2012; 59:997-1003
40. Mehlen P, Furne C: Netrin-1: when a neuronal guidance cue turns out to be a regulator of tumorigenesis. Cell Mol Life Sci 2005; 62: 2599-2616
41. Grant A, Fathalli F, Rouleau G, et al: Association between schizophrenia and genetic variation in DCC: a case-control study. Schizophr Res 2012; 137:26-31
42. Zhang C, Gao J, Zhang H, et al: Robo2-slit and Dcc-netrin1 coordinate neuron axonal pathfinding within the embryonic axon tracts. J Neurosci 2012; 32:12589-12602
43. Grant A, Hoops D, Labelle-Dumais C, et al: Netrin-1 receptordeficient mice show enhanced mesocortical dopamine transmission and blunted behavioural responses to amphetamine. Eur J Neurosci 2007; 26:3215-3228
44. Srour M, Rivière JB, Pham JM, et al: Mutations in DCC cause congenital mirror movements. Science 2010; 328:592
45. Shirakawa O, Kitamura N, Lin XH, et al: Abnormal neurochemical asymmetry in the temporal lobe of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2001; 25:867-877
46. Courchet J, Polleux F: Sonic hedgehog, BOC, and synaptic development: new players for an old game. Neuron 2012; 73:1055-1058
47. Harwell CC, Parker PR, Gee SM, et al: Sonic hedgehog expression in corticofugal projection neurons directs cortical microcircuit formation. Neuron 2012; 73:1116-1126
48. Connor RM, Allen CL, Devine CA, et al: BOC, brother of CDO, is a dorsoventral axon-guidance molecule in the embryonic vertebrate brain. J Comp Neurol 2005; 485:32-42
49. Maeno-Hikichi Y, Chang S, Matsumura K, et al: A PKC epsilon- ENH-channel complex specifically modulates N-type Ca2+ channels. Nat Neurosci 2003; 6:468-475
50. Remedios R, Subramanian L, Tole S: LIM genes parcellate the embryonic amygdala and regulate its development. J Neurosci 2004; 24:6986-6990
51. Jeleń F, Oleksy A, Smietana K, et al: PDZ domains: common players in the cell signaling. Acta Biochim Pol 2003; 50:985-1017
52. Lang B, Alrahbeni TM, Clair DS, et al: HDAC9 is implicated in schizophrenia and expressed specifically in post-mitotic neurons but not in adult neural stem cells. Am J Stem Cells 2012; 1:31-41
53. Sugo N, Oshiro H, Takemura M, et al: Nucleocytoplasmic translocation of HDAC9 regulates gene expression and dendritic growth in developing cortical neurons. Eur J Neurosci 2010; 31:1521-1532
54. Phiel CJ, Zhang F, Huang EY, et al: Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 2001; 276:36734-36741
55. Kurita M, Holloway T, García-Bea A, et al: HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity. Nat Neurosci 2012; 15:1245-1254
56. Spalding KL, Bergmann O, Alkass K, et al: Dynamics of hippocampal neurogenesis in adult humans. Cell 2013; 153:1219-1227
57. Eisch AJ, Cameron HA, Encinas JM, et al: Adult neurogenesis, mental health, and mental illness: hope or hype? J Neurosci 2008; 28:11785-11791
58. Toro CT, Deakin JF: Adult neurogenesis and schizophrenia: a window on abnormal early brain development? Schizophr Res 2007; 90:1-14
59. Stənescu L, Georgescu G, Zaharescu J, et al: [Dynamic aspects of blood gastrin after antral stimulation.] Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna 1978; 30:311-318 (Romanian)
60. Keshavan MS, Mallinger AG, Pettegrew JW, et al: Erythrocyte membrane phospholipids in psychotic patients. Psychiatry Res 1993; 49:89-95
61. Walss-Bass C, Soto-Bernardini MC, Johnson-Pais T, et al: Methionine sulfoxide reductase: a novel schizophrenia candidate gene. Am J Med Genet B Neuropsychiatr Genet 2009; 150B: 219-225
62. Ma X, Deng W, Liu X, et al: A genome-wide association study for quantitative traits in schizophrenia in China. Genes Brain Behav 2011; 10:734-739
63. Yao JK, Keshavan MS: Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view. Antioxid Redox Signal 2011; 15:2011-2035
64. Flatow J, Buckley P, Miller BJ: Meta-analysis of oxidative stress in schizophrenia. Biol Psychiatry 2013; 74:400-409
65. Stahl SM: Beyond the dopamine hypothesis to the NMDA glutamate receptor hypofunction hypothesis of schizophrenia. CNS Spectr 2007; 12:265-268
66. Kaufmann CA, Suarez B, Malaspina D, et al: NIMH Genetics Initiative Millenium Schizophrenia Consortium: linkage analysis of African-American pedigrees. Am J Med Genet 1998; 81:282-289
67. Ophoff RA, Escamilla MA, Service SK, et al: Genomewide linkage disequilibrium mapping of severe bipolar disorder in a population isolate. Am J Hum Genet 2002; 71:565-574
68. Matsumoto J, Sugiura Y, Yuki D, et al: Abnormal phospholipids distribution in the prefrontal cortex from a patient with schizophrenia revealed by matrix-assisted laser desorption/ionization imaging mass spectrometry. Anal Bioanal Chem 2011; 400:1933-1943
69. Law MH, Cotton RG, Berger GE: The role of phospholipases A2 in schizophrenia. Mol Psychiatry 2006; 11:547-556
70. Ross BM, Hughes B, Kish SJ, et al: Serum calcium-independent phospholipase A2 activity in bipolar affective disorder. Bipolar Disord 2006; 8:265-270
71. Smesny S, Schmelzer CE, Hinder A, et al: Skin ceramide alterations in first-episode schizophrenia indicate abnormal sphingolipid metabolism. Schizophr Bull 2013; 39:933-941
72. Iwamoto K, Bundo M, Kato T: Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum Mol Genet 2005; 14:241-253
73. Lee BD, Walss-Bass C, Thompson PM, et al: Malic enzyme 2 and susceptibility to psychosis and mania. Psychiatry Res 2007; 150:1-11
74. Liu Y, Zhang H, Ju G, et al: A study of the PEMT gene in schizophrenia. Neurosci Lett 2007; 424:203-206
75. Paoletti L, Elena C, Domizi P, et al: Role of phosphatidylcholine during neuronal differentiation. IUBMB Life 2011; 63:714-720
76. Allen NJ, Bennett ML, Foo LC, et al: Astrocyte glypicans 4 and 6 promote formation of excitatory synapses via GluA1 AMPA receptors. Nature 2012; 486:410-414
77. Yao PJ, Coleman PD, Calkins DJ: High-resolution localization of clathrin assembly protein AP180 in the presynaptic terminals of mammalian neurons. J Comp Neurol 2002; 447:152-162
78. Cho JH, Oh DY, Kim HJ, et al: The TSP motif in AP180 inhibits phospholipase D1 activity resulting in increased efficacy of anticancer drug via its direct binding to carboxyl terminal of phospholipase D1. Cancer Lett 2011; 302:144-154
79. Kohn AD, Moon RT: Wnt and calcium signaling: beta-cateninin-dependent pathways. Cell Calcium 2005; 38:439-446
80. Goes FS, Hamshere ML, Seifuddin F, et al: Genome-wide association of mood-incongruent psychotic bipolar disorder. Transl Psychiatr 2012; 2:e180
81. Mayilyan KR, Weinberger DR, Sim RB: The complement system in schizophrenia. Drug News Perspect 2008; 21:200-210
82. Håvik B, Le Hellard S, Rietschel M, et al: The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia. Biol Psychiatry 2011; 70:35-42
83. Schizophrenia Working Group of the Psychiatric Genomics Consortium: Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014; 511:421-427
84. Stephan AH, Barres BA, Stevens B: The complement system: an unexpected role in synaptic pruning during development and disease. Annu Rev Neurosci 2012; 35:369-389
85. Maier M, Peng Y, Jiang L, et al: Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic mice. J Neurosci 2008; 28: 6333-6341
86. Weksler ME, Gouras G, Relkin NR, et al: The immune system, amyloid-beta peptide, and Alzheimer's disease. Immunol Rev 2005; 205:244-256
87. Rudduck C, Beckman L, Franzén G, et al: C3 and C6 complement types in schizophrenia. Hum Hered 1985; 35:255-258
88. Boulanger LM: Immune proteins in brain development and synaptic plasticity. Neuron 2009; 64:93-109
89. owen mj, o'donovan mc, thapar a, et al: neurodevelopmental hypothesis of schizophrenia. br j psychiatry 2011; 198: 173-175
90. Guilmatre A, Dubourg C, Mosca AL, et al: Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation. Arch Gen Psychiatry 2009; 66:947-956
91. Gilman SR, Chang J, Xu B, et al: Diverse types of genetic variation converge on functional gene networks involved in schizophrenia. Nat Neurosci 2012; 15:1723-1728
92. Greenwood TA, Lazzeroni LC, Murray SS, et al: Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry 2011; 168:930-946
93. Greenwood TA, Light GA, Swerdlow NR, et al: Association analysis of 94 candidate genes and schizophrenia-related endophenotypes. PLoS ONE 2012; 7:e29630
94. O'Dushlaine C, Kenny E, Heron E, et al: Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility. Mol Psychiatry 2011; 16:286-292
95. Juraeva D, Haenisch B, Zapatka M, et al: Integrated pathway-based approach identifies association between genomic regions at CTCF and CACNB2 and schizophrenia. PLoS Genet 2014; 10: e1004345
96. Jia P, Wang L, Meltzer HY, et al: Common variants conferring risk of schizophrenia: a pathway analysis of GWAS data. Schizophr Res 2010; 122:38-42